Citizens Financial Group Inc. RI Buys New Position in Corteva, Inc. $CTVA

Citizens Financial Group Inc. RI bought a new stake in shares of Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor bought 17,370 shares of the company’s stock, valued at approximately $1,471,000.

Other institutional investors also recently made changes to their positions in the company. JPL Wealth Management LLC bought a new position in shares of Corteva in the third quarter valued at approximately $25,000. Garton & Associates Financial Advisors LLC bought a new stake in Corteva during the fourth quarter worth approximately $27,000. Bank of Jackson Hole Trust acquired a new stake in Corteva in the fourth quarter worth approximately $28,000. Cornerstone Financial Management LLC bought a new position in Corteva during the 4th quarter valued at $29,000. Finally, Elevation Wealth Partners LLC increased its position in shares of Corteva by 334.6% during the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after purchasing an additional 261 shares during the period. 81.54% of the stock is owned by institutional investors and hedge funds.

Corteva Stock Up 2.6%

Shares of Corteva stock opened at $77.97 on Wednesday. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $90.97. The firm has a market capitalization of $52.02 billion, a PE ratio of 51.64, a price-to-earnings-growth ratio of 2.35 and a beta of 0.57. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The stock’s fifty day moving average is $81.84 and its 200-day moving average is $80.12.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. During the same quarter last year, the business posted $2.20 EPS. Corteva’s revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s payout ratio is currently 47.68%.

Analyst Ratings Changes

A number of research firms have recently commented on CTVA. CICC Research boosted their price objective on Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. Weiss Ratings lowered Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 3rd. Oppenheimer boosted their price target on shares of Corteva from $89.00 to $95.00 and gave the stock an “outperform” rating in a research report on Thursday, July 23rd. JPMorgan Chase & Co. raised their price objective on shares of Corteva from $77.00 to $83.00 and gave the company a “neutral” rating in a research report on Monday, August 3rd. Finally, BMO Capital Markets lifted their price objective on shares of Corteva from $95.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, August 3rd. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, Corteva presently has an average rating of “Moderate Buy” and an average target price of $91.50.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.